If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINL.L Regulatory News (INL)

  • There is currently no data for INL

Director/PDMR Shareholding

1 Oct 2007 12:16

Inland PLC01 October 2007 For immediate release 1 October 2007 Inland Plc ("Inland" or "the Company") Director/PDMR Shareholding Inland received notification on 1 October 2007 pursuant to the FSA Disclosureand Transparency Rules and AIM Rule 17 that, Stephen Wicks (Chief Executive) andNishith Malde (Finance Director) have today each acquired 50,000 Ordinary Sharesof 10 pence each in the capital of the Company ("Ordinary Shares"), at a pricesof 45.88p and 46p per Ordinary Share respectively. The shares acquired byNishith Malde were purchased on his behalf by the trustees of his personalpension fund. Stephen Wicks now holds 20,100,009 Ordinary Shares representing12.40% of the issued ordinary share capital. Nishith Malde now holds 8,074,000 Ordinary Shares representing 4.98% of the issued ordinary sharecapital. Enquiries please contact: Inland Plc Tel: 01923 713 600Stephen Wicks, Chief ExecutiveNishith Malde, Finance Director Dawnay, Day Corporate Finance Limited, Nominated Tel: 020 7509 4570Adviser David FloydAlex Stanbury KBC Peel Hunt Ltd, Broker Tel: 020 7418 8900Julian BluntNicholas Marren This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jan 20236:04 pmRNSAnnual Financial Report
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
25th Jan 20237:00 amRNSSale of Strategic Land Portfolio & Trading Update
16th Jan 20232:05 pmRNSSecond Price Monitoring Extn
16th Jan 20232:00 pmRNSPrice Monitoring Extension
16th Jan 202312:58 pmRNSDirectorate Change
12th Jan 20239:27 amRNSOption Exercise & Transfer of Treasury Shares
6th Dec 20227:00 amRNSAppointment of new CEO
14th Oct 20227:00 amRNSMajor Planning Application Approval
30th Sep 20227:00 amRNSUpdate on facility, asset management & land sales
28th Sep 202211:06 amRNSSecond Price Monitoring Extn
28th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSDirector/PCA Dealing
12th Sep 20227:00 amRNSDirector/PCA Dealing
6th Sep 202211:05 amRNSSecond Price Monitoring Extn
6th Sep 202211:00 amRNSPrice Monitoring Extension
6th Sep 20229:00 amRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSBoard changes, strategic review & trading update
6th Sep 20227:00 amRNSTransaction in Own Shares
5th Sep 20227:00 amRNSTransaction in Own Shares
2nd Sep 20227:00 amRNSTransaction in Own Shares
31st Aug 20227:00 amRNSTransaction in Own Shares
30th Aug 20227:00 amRNSTransaction in Own Shares
26th Aug 20227:00 amRNSTransaction in Own Shares
25th Aug 20227:00 amRNSTransaction in Own Shares
24th Aug 20227:00 amRNSTransaction in Own Shares
22nd Aug 20227:00 amRNSTransaction in Own Shares
19th Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares
17th Aug 20227:00 amRNSTransaction in Own Shares
16th Aug 20227:00 amRNSTransaction in Own Shares
15th Aug 20227:00 amRNSTransaction in Own Shares
11th Aug 20227:00 amRNSTransaction in Own Shares
10th Aug 20227:00 amRNSTransaction in Own Shares
9th Aug 20227:00 amRNSTransaction in Own Shares
8th Aug 20227:00 amRNSTransaction in Own Shares
5th Aug 20227:00 amRNSTransaction in Own Shares
4th Aug 20227:00 amRNSTransaction in Own Shares
3rd Aug 20227:00 amRNSAppointment of new Auditors
3rd Aug 20227:00 amRNSTransaction in Own Shares
2nd Aug 20227:00 amRNSTransaction in Own Shares
1st Aug 20227:00 amRNSTransaction in Own Shares
29th Jul 20227:00 amRNSTransaction in Own Shares
28th Jul 20227:00 amRNSTransaction in Own Shares
27th Jul 20227:00 amRNSTransaction in Own Shares
26th Jul 20227:00 amRNSTransaction in Own Shares
25th Jul 20227:00 amRNSTransaction in Own Shares
22nd Jul 20222:05 pmRNSSecond Price Monitoring Extn
22nd Jul 20222:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.